Biotech · Private company
Medivation, Inc.
Track this companyFree. Adds Medivation, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials224 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials22
- A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 23, 2017ClinicalTrials.gov NCT03246347 · fetched Nov 12, 2026
- A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate CancerPHASE2 · COMPLETED · started Jul 4, 2017ClinicalTrials.gov NCT03148795 · fetched Nov 12, 2026
- An Open-Label Pharmacokinetics and Safety Study of TalazoparibPHASE1 · COMPLETED · started Feb 21, 2017ClinicalTrials.gov NCT02997163 · fetched Nov 12, 2026
- Open-Label Extension and Safety Study of TalazoparibPHASE2 · COMPLETED · started Nov 8, 2016ClinicalTrials.gov NCT02921919 · fetched Nov 12, 2026
- A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Oct 13, 2016ClinicalTrials.gov NCT03042910 · fetched Nov 12, 2026
- An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)PHASE1 · COMPLETED · started Sep 30, 2016ClinicalTrials.gov NCT02997176 · fetched Nov 12, 2026
- Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate CancerPHASE1 · COMPLETED · started Jun 22, 2016ClinicalTrials.gov NCT02339168 · fetched Nov 12, 2026
- Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast CancerPHASE2 · ACTIVE_NOT_RECRUITING · started May 19, 2016ClinicalTrials.gov NCT02750358 · fetched Nov 12, 2026
- Randomized Salvage Radiation Therapy Plus Enzalutamide Post ProstatectomyPHASE2 · COMPLETED · started Mar 28, 2015ClinicalTrials.gov NCT02203695 · fetched Nov 12, 2026
- Enzalutamide/Leuprolide +/- Abiraterone/Pred in ProstatePHASE2 · COMPLETED · started Oct 1, 2014ClinicalTrials.gov NCT02268175 · fetched Nov 12, 2026
- Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Sep 23, 2014ClinicalTrials.gov NCT01990196 · fetched Nov 12, 2026
- PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid TumorsPHASE1 · COMPLETED · started Jun 12, 2014ClinicalTrials.gov NCT02049593 · fetched Nov 12, 2026
- Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 2, 2014ClinicalTrials.gov NCT02023463 · fetched Nov 12, 2026
- Enzalutamide + External Beam Rt For ProstatePHASE2 · COMPLETED · started Feb 1, 2014ClinicalTrials.gov NCT02028988 · fetched Nov 12, 2026
- Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerPHASE3 · UNKNOWN · started Jan 22, 2014ClinicalTrials.gov NCT01949337 · fetched Nov 12, 2026
- Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast CancerPHASE2 · COMPLETED · started Dec 16, 2013ClinicalTrials.gov NCT02007512 · fetched Nov 12, 2026
- A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)PHASE2 · TERMINATED · started Dec 13, 2013ClinicalTrials.gov NCT02034916 · fetched Nov 12, 2026
- Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior TherapiesPHASE2 · COMPLETED · started Nov 5, 2013ClinicalTrials.gov NCT01974765 · fetched Nov 12, 2026
- A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)PHASE3 · COMPLETED · started Oct 14, 2013ClinicalTrials.gov NCT01945775 · fetched Nov 12, 2026
- Study of Enzalutamide in Patients With Castration-resistant Prostate CancerPHASE2 · COMPLETED · started Sep 13, 2013ClinicalTrials.gov NCT01942837 · fetched Nov 12, 2026
- Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsPHASE1 · COMPLETED · started Jan 3, 2011ClinicalTrials.gov NCT01286987 · fetched Nov 12, 2026
- Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced RemissionPHASE2 · COMPLETED · started May 1, 2010ClinicalTrials.gov NCT01096602 · fetched Nov 12, 2026